Effects of Nitroglycerin Versus Labetalol on Tissue Perfusion During Deliberate Hypotension

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 19, 2019

Primary Completion Date

May 25, 2019

Study Completion Date

May 25, 2019

Conditions
Tissue PerfusionDeliberate HypotensionSinus Endoscopic Surgery
Interventions
DRUG

Nitroglycerin

Nitroglycerin is a direct vasodilator and its main action is through venodilation. Nitroglycerin will be diluted by adding 3 mL (3 mg) to 47 mL normal saline in a 50 mL syringe and will be infused after endotracheal intubation with a starting dose of 0.5 mL/Kg/ hr to have a starting dose of 0.5 μg/Kg/min. The rate of nitroglycerin infusion will be 0.5-2 μg /kg/min .The infusion rate will be finely adjusted to maintain MAP around 55-65mmHg or till reaching adequate surgical field {defined as surgical field score (SFS) \<3}.

DRUG

Labetalol

Labetalol is an α and β - adrenergic receptors competitive antagonist. Labetalol will be diluted by adding 10 mL (50 mg) to 40 mL normal saline in a 50 mL syringe and will be infused after endotracheal intubation with a starting dose of 0.5 mL/Kg/ hr. The rate of Labetalol infusion will be 0.5-2 mg/kg/h.The infusion rate will be finely adjusted to maintain MAP around 55-65mmHg or till reaching adequate surgical field {defined as surgical field score (SFS) \<3}.

Trial Locations (1)

11562

Kasr Al Ainy, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03809065 - Effects of Nitroglycerin Versus Labetalol on Tissue Perfusion During Deliberate Hypotension | Biotech Hunter | Biotech Hunter